Italian expert‐based recommendations on the use of photo(chemo)therapy in the management of mycosis fungoides: Results of an e‐Delphi consensus

Phototherapy is a mainstay for the treatment of MF. However, there is scarce evidence for its use, mostly due to the lack of a unified schedule.

[1]  M. Fimiani,et al.  Clinical and histological evaluation in patients with mycosis fungoides treated with UVA1. , 2020, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[2]  N. Pimpinelli,et al.  Real-life use of phototherapy in early-stage mycosis fungoides from the Cutaneous Lymphoma Commission of the Italian Lymphoma Foundation: results of a web-based survey. , 2018, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[3]  A. Stratigos,et al.  Phototherapy as a first‐line treatment for early‐stage mycosis fungoides: The results of a large retrospective analysis , 2018, Photodermatology, photoimmunology & photomedicine.

[4]  N. Pimpinelli,et al.  Standardization of regimens in Narrowband UVB and PUVA in early stage mycosis fungoides: position paper from the Italian Task Force for Cutaneous Lymphomas , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  J. Scarisbrick,et al.  The Results of Low-Dose Total Skin Electron Beam Radiation Therapy (TSEB) in Patients With Mycosis Fungoides From the UK Cutaneous Lymphoma Group. , 2017, International journal of radiation oncology, biology, physics.

[6]  R. Wilcox,et al.  Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management , 2017, American journal of hematology.

[7]  A. Pileri,et al.  Maintenance phase in psoralen–ultraviolet A phototherapy of early‐stage mycosis fungoides. A critically appraised topic , 2017, The British journal of dermatology.

[8]  R. Willemze,et al.  Recommendations for treatment in folliculotropic mycosis fungoides: report of the Dutch Cutaneous Lymphoma Group , 2017, The British journal of dermatology.

[9]  M. Duvic,et al.  Extracorporeal photopheresis for the treatment of early‐stage mycosis fungoides , 2017, Dermatologic therapy.

[10]  C. Klemke,et al.  European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017. , 2017, European journal of cancer.

[11]  Patrick K. Lee,et al.  Revisiting the History and Importance of Phototherapy in Dermatology. , 2017, JAMA dermatology.

[12]  E. Adışen,et al.  Ultraviolet A1 Phototherapy in the Treatment of Early Mycosis Fungoides , 2017, Dermatology.

[13]  M. Kaminski,et al.  A retrospective comparative outcome analysis following systemic therapy in Mycosis fungoides and Sezary syndrome , 2016, American journal of hematology.

[14]  Mary P. Tully,et al.  How to use the nominal group and Delphi techniques , 2016, International Journal of Clinical Pharmacy.

[15]  R. Hoppe,et al.  Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials. , 2015, Journal of the American Academy of Dermatology.

[16]  C. Conrad,et al.  The Dermatologists' Role in Managing Psoriatic Arthritis: Results of a Swiss Delphi Exercise Intended to Improve Collaboration with Rheumatologists , 2015, Dermatology.

[17]  M. Beyer,et al.  Systematic review of combination therapies for mycosis fungoides. , 2014, Cancer treatment reviews.

[18]  T. Grantcharov,et al.  Determining the Role of a National Objective Assessment of Surgical Skills in Gynecological Oncology: An e-Delphi Methodology , 2014, International Journal of Gynecologic Cancer.

[19]  Paola Savoia,et al.  Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T‐cell lymphoma: a single center clinical experience with long‐term follow‐up data and a brief overview of the literature , 2013, International journal of dermatology.

[20]  Kathryn Holloway.  Doing the E-Delphi: Using Online Survey Tools , 2012, Computers, informatics, nursing : CIN.

[21]  F. Trautinger.  Phototherapy of mycosis fungoides , 2011, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[22]  C. Antoniou,et al.  PUVA plus interferon α2b in the treatment of advanced or refractory to PUVA early stage mycosis fungoides: a case series , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[23]  M. Apetato,et al.  Efficacy of narrowband UVB vs. PUVA in patients with early‐stage mycosis fungoides , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[24]  S. Whittaker,et al.  How I treat mycosis fungoides and Sézary syndrome. , 2009, Blood.

[25]  H. Wong,et al.  Bexarotene and narrowband ultraviolet B phototherapy combination treatment for mycosis fungoides , 2007, Photodermatology, photoimmunology & photomedicine.

[26]  G. Borroni,et al.  Narrow‐band ultraviolet therapy in early‐stage mycosis fungoides: study on 20 patients , 2007, Photodermatology, photoimmunology & photomedicine.

[27]  I. Amin,et al.  Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early‐stage mycosis fungoides: a right–left comparative study , 2005, Photodermatology, photoimmunology & photomedicine.

[28]  R. Reznick,et al.  Objective structured assessment of technical skill (OSATS) for surgical residents , 1997, The British journal of surgery.

[29]  R. Hoppe,et al.  PUVA treatment of erythrodermic and plaque-type mycosis fungoides. Ten-year follow-up study. , 1987, Archives of dermatology.

[30]  R. Hoppe,et al.  PUVA treatment of erythrodermic and plaque type mycosis fungoides. , 1981, Journal of the American Academy of Dermatology.

[31]  J. Parrish,et al.  Oral methoxsalen photochemotherapy of mycosis fungoides , 1976, Cancer.

[32]  N. Dalkey,et al.  An Experimental Application of the Delphi Method to the Use of Experts , 1963 .

[33]  V. Brazzelli,et al.  Photo-photochemotherapy in Juvenile-onset Mycosis Fungoides: A Retrospective Study on 9 Patients , 2019, Journal of pediatric hematology/oncology.

[34]  N. Pimpinelli,et al.  Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides , 2016, European Journal of Dermatology.

[35]  E. Olsen,et al.  Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium. , 2016, Journal of the American Academy of Dermatology.